首页> 外国专利> Use of small molecule glycosidically bound terminal galactosides and fucosides to bind toxins acting as galectin in the treatment of poisoning, particularly in the case of ricin poisoning

Use of small molecule glycosidically bound terminal galactosides and fucosides to bind toxins acting as galectin in the treatment of poisoning, particularly in the case of ricin poisoning

机译:使用小分子糖苷结合的末端半乳糖叶糖苷和岩藻糖苷来结合毒素作为半乳糖蛋白的治疗中毒,特别是在蓖麻毒素中毒的情况下

摘要

The invention relates to the use of low-molecular glycosidic compounds with terminal D-galactose and L-fucose in the treatment of intoxications with ricin. The identified compounds form a lectin bond with the B chain of the ricin and thereby prevent further endocytosis of the toxins. The compounds should be ingested as early as possible after incorporation of the toxin and can also be used preventively. The groups bonded to the D-galactose and L-fucose can be other saccharides (e.g. fructose), polyalcohols (e.g. sorbitol), diacyl-glycerides or flavonoids (e.g. quercetin). Galactose-heteropolysaccharide hydrolysates such as guar gum flour can also be used. The identified compounds can be used for oral, pulmonary and systemic intoxications. They should be used in corresponding pharmaceutical forms of administration. The compounds are dosed in molar excess.
机译:本发明涉及使用末端D-半乳糖和L-岩藻糖的低分子糖苷化合物在治疗中蓖麻毒素的用途。 所鉴定的化合物与蓖麻植物的B链形成凝集素键,从而防止毒素的进一步内吞作用。 应尽早在掺入毒素后尽早摄取化合物,也可以预防地使用。 键合到D-半乳糖和L-岩藻糖的基团可以是其他糖(例如果糖),多元醇(例如山梨糖醇),二酰甘油酯或黄酮(例如槲皮素)。 也可以使用半乳糖 - 杂多糖水解产物,例如瓜尔胶面粉。 所鉴定的化合物可用于口服,肺和全身毒害。 它们应该用于相应的药物形式的给药。 化合物以摩尔过量给药。

著录项

  • 公开/公告号DE112019007322A5

    专利类型

  • 公开/公告日2022-02-17

    原文格式PDF

  • 申请/专利权人 ILMA BIOCHEM GMBH;

    申请/专利号DE201911007322T

  • 发明设计人 KATHARINA HOLTKAMP;

    申请日2019-12-13

  • 分类号A61K31/7042;A61K31/736;A61K31/7048;A61P1/12;A61K31/7032;A61K31/702;A61P39/02;A61K31/7016;

  • 国家 DE

  • 入库时间 2022-08-24 23:39:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号